Additek Life Sciences Private Limited
About Additek Life Sciences Private Limited
Data last updated:
Additek Life Sciences Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2016PTC085675. Its GSTIN is 24AAOCA1026H2ZZ (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mitul Narandas Nariawala and Nipul Shah.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at C – 23 Prarambh Resicum Plaza Waghodiya Road, Vadodara, Gujarat, India – 390019.
As per the financials filed for FY 2019, the company reported a revenue of ₹2.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹54,471 (net margin 0.3%) and EBITDA of ₹3.17 Lakh (EBITDA margin 1.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Additek Life Sciences Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 23 Prarambh Resicum Plaza Waghodiya Road, Vadodara, Gujarat, India – 390019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Additek Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Additek Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Additek Life Sciences Private Limited, buy the company report.
Financials of Additek Life Sciences Private Limited
FY 2022 filings availableAdditek Life Sciences Private Limited reported revenue of ₹2.01 Cr (up 187% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 187% in the latest year. EBITDA rose 98% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹2.01 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.17 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹54,471 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Additek Life Sciences Private Limited, buy the company report.
Board of directors of Additek Life Sciences Private Limited
Additek Life Sciences has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mitul Narandas Nariawala | Director | 11 Jan 2016 | 10 Years 10 Months | Current |
| Nipul Shah Also directs: BRG Pharmaceuticals Private Limited | Director | 11 Jan 2016 | 10 Years 10 Months | Current |
Peer comparison
Additek Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Planet Herbs Lifesciences Private Limited | ₹2.02 Cr (FY 2024) | -12.0% | New Delhi, Delhi, India | |||
| Kind Health and Hygiene Private Limited | ₹2.02 Cr (FY 2025) | -35.0% | Junnar, Maharashtra, India | |||
| Additek Life Sciences Private Limitedthis company | ₹2.01 Cr (FY 2019) | ₹54,471 | 0.3% | 187.0% | Vadodara, Gujarat, India | |
| Merino Laboratories Private Limited | ₹2 Cr (FY 2025) | 404.0% | Hyderabad, Telangana, India | |||
| Tri Medix Pharma Private Limited | ₹1.99 Cr (FY 2025) | 11.0% | Chandigarh, India |
To see the full peer comparison of Additek Life Sciences Private Limited, buy the company report.
Auditor
Additek Life Sciences Private Limited is audited by D S S P & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D S S P & ASSOCIATES | FY 2019 | 141312W |
Shareholding
The shareholding of Additek Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Additek Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Additek Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Additek Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Additek Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAOCA1026H2ZZ | Gujarat | Active | 29 Aug 2017 |
To see the full GST registrations and return filing status of Additek Life Sciences Private Limited, buy the company report.
Recent activity
Additek Life Sciences Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Hemang Harshadray Joshi ceased to be Additional Director on 30 Sep 2017.
Frequently asked questions
Additek Life Sciences is an active private limited company based in Vadodara, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2016 (10+ years old) and is registered under CIN U24100GJ2016PTC085675.
Additek Life Sciences has 2 current directors:
- Mitul Narandas Nariawala - Director
- Nipul Shah - Director
The latest financial statements of Additek Life Sciences on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Additek Life Sciences is 24AAOCA1026H2ZZ, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Additek Life Sciences is U24100GJ2016PTC085675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Additek Life Sciences was incorporated on 11 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Additek Life Sciences by revenue are Planet Herbs Lifesciences Private Limited, Kind Health and Hygiene Private Limited, Merino Laboratories Private Limited, Tri Medix Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hemang Harshadray Joshi ceased to be Additional Director on 30 Sep 2017. Gauravkumar Shivnarayansinh Chauhan ceased to be Additional Director on 11 Jul 2017. Hardik Bharat Shah ceased to be Director on 11 Jul 2017. Additek Life Sciences has 6 board changes on record in total.
The registered office of Additek Life Sciences is at C – 23 Prarambh Resicum Plaza Waghodiya Road, Vadodara, Gujarat, India – 390019.
Additek Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Additek Life Sciences is compliant as of 24 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
